The average duration of follow-up on the initial ART regimen was 1.9 years. In comparison to efavirenz/tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC), initiating bictegravir/TAF/FTC 3.9 kg [95 percent CI: 2.2 to 5.5] and dolutegravir/TAF/FTC [4.4 kg (95 percent CI: 2.1 to 6.6)] were associated with the greatest weight gain in the immediate period, followed by darunavir/TDF/ In comparison to efavirenz/TDF/FTC, initiating darunavir/TDF/FTC was associated with a 1.0 kg (95 percent CI: 0.5 to 1.5) per 6-months greater weight gain, whereas dolutegravir/abacavir/FTC was associated with a 0.6-kg (95 percent CI: 0.3 to 0.9) and dolutegravir/TDF/FTC was associated with a 0.6-kg (95 percent Weight gain was significantly higher with dolutegravir/abacavir/FTC and darunavir/TDF/FTC than with several integrase inhibitor-based regimens. Conclusions: Weight gain following ART initiation differs by regimen in previously ART-naive PLWH; we observed greater gain in PLWH taking newer integrase strand transfer inhibitors (DTG, BIC) and DRV-based regimens.
Background: We sought to identify factors associated with weight gain in antiretroviral therapy (ART) switch randomized clinical trials.
Methods: In a pooled analysis of 12 prospective clinical trials in which virologically suppressed people living with human immunodeficiency virus (PWH) were randomized to switch or remain on a stable baseline regimen, we investigated the effects of demographic factors, clinical characteristics, and ART on weight gain (SBR).
Weight gain was greater in more recent trials and when using newer ART regimens. A pooled analysis revealed that baseline demographic factors such as lower CD4 cell count, higher HIV type 1 RNA, no injection drug use, female sex, and black race were associated with weight gain. The use of integrase strand transfer inhibitors was associated with more weight gain than the use of protease inhibitors or nonnucleoside reverse transcriptase inhibitors (NNRTIs), with dolutegravir and bictegravir being associated with more weight gain than elvitegravir/cobicistat. Among the NNRTIs, rilpivirine was linked to a higher rate of weight gain than efavirenz. Tenofovir alafenamide was associated with more weight gain than tenofovir disoproxil fumarate, abacavir, or zidovudine among nucleoside/nucleotide reverse transcriptase inhibitors. Conclusions: Weight gain is common in ART initiation clinical trials and is multifactorial in nature, with demographic factors, HIV-related factors, and ART regimen composition all playing a role. The mechanisms by which certain ART agents contribute differentially to weight gain are unknown.
HEY, WHAT ARE YOU DOING?
Just kidding, I'm aware that some of my games are less than stellar. Still working on Fortunes Feast- I'm proud of where it's at, but I got a lot of flak for how I handled Fantastic Dungeon Extender and other things. Whatever- Specifically, Quest (for obvious reasons) does not allow you to import saved games into newer versions, so it was a pain to redo everything, which led to me implementing items that allow you to skip parts, which led to the game breaking in horrible ways, which led to MORE complaints, which led to me just kinda wrapping the game up, presenting it as it was, and then not touching it again.
Weight Gain Artinya
Weight Gain Articles
3. Can I gain weight by eating only fruits or dry fruits? Ans: In addition to eating fruits and dry fruits to gain weight, you should also eat a well-balanced, high-calorie diet. Eating only fruits or dry fruits is also not a good way to gain weight. On the contrary, it can cause side effects such as poor digestion and health problems.
Fortunately, there are a plethora of diets that, if followed, should help you lose weight while also providing you with the nutrition you require. What should you do, however, if you want to gain weight in a healthy way? Is it possible to gain weight without jeopardizing your health? According to Kaylee Jacks, a sports dietitian with Texas Health Sports Medicine in Dallas, some people may want to gain weight for a variety of health, aesthetic, or physiological reasons. Individuals with Crohn's disease, a chronic autoimmune disorder of the intestine, for example, have difficulty gaining and maintaining weight.
Stu is seriously injured in a terrible motorcycle accident while on his way to conversion. Following his recovery, the former agnostic begins to wonder if there isn't something else for him and decides that rather than marrying his girlfriend, he will go all in and become a priest. When he is diagnosed with an incurable degenerative muscle disease, staying on the straight and narrow becomes even more difficult.
Although there have been numerous studies on weight loss and weight gain in OA, she explained that the majority of them have focused on weight loss rather than gain, and on OA in the knee rather than the hip.
The current study sought to investigate the impact of both weight gain and weight loss on radiographic outcomes (KL grade change, medial JSN), symptomatic outcomes (knee pain and resolution at 12 months), and the need for joint replacement in people with hip or knee OA.
Weight Gain Arthritis
